Presentation is loading. Please wait.

Presentation is loading. Please wait.

TRCC Patient and Investigator Pools Workgroup November Status Report.

Published bySibyl Baker Modified over 8 years ago

Similar presentations

Presentation on theme: "TRCC Patient and Investigator Pools Workgroup November Status Report."— Presentation transcript:

1 TRCC Patient and Investigator Pools Workgroup November Status Report

2 Investigator and Patient Pools Workgroup John Roache Joe McCormick Deborah Mote Kim Medellin Mary Weyant Blair Holbein Adrianne Rhea Don Powell Bill Calhoun Kristin Parks Dan Karp Mike Fallon Kathy Franco

3 Key Initiative #1: Create master list of clinical trial investigators/ research specialties Intent (why): Promote trials & network investigators Knowledge of local Investigator and Patient Resources is Important Established research groups have group databases and CRU’s generally can list their investigators, but no CTSA has ready access to institutional lists, or databases. Most CTSA’s believe they could create a list or obtain the information through a laborious manual process, but no such list exists now; A ready and accessible database would be helpful …but,  Velos may (or may not) be the solution, some years down the road;  Not clear that IT resources are available or that effort/expense justifies the need.

4 Key Initiative #1: Create master list of clinical trial investigators/ research specialties Intent (why): Promote trials & network investigators Knowledge of local Investigator and Patient Resources is Important Established research groups have group databases and CRU’s generally can list their investigators, but no CTSA has ready access to institutional lists, or databases. Most CTSA’s believe they could create a list or obtain the information through a laborious manual process, but no such list exists now; A ready and accessible database would be helpful …but,  Velos may (or may not) be the solution, some years down the road;  Not clear that IT resources are available or that effort/expense justifies the need. ACTION ITEM(S): The Group will assure that single “Points of Contact” are available and identifiable so that collaborative Network Trials are facilitated. Work towards growing and maintaining lists of trials Investigators and Patient Pools and implement VELOS in ways to support this automatically.

5 Key Initiative #2: Identify & support a multi-site NIH/ Federal trial within the TRCC Network Intent (why): Support a network trial Study 1:Neurological Emergencies Treatment Trials (NETT) Sponsor:NIH/NETT PI:Elizabeth Jones (UT-H) Co.I. (Sites):Mileski/Powell (UTMB) Study 2:Genetic Risks for Bicuspid Aortic Valve Disease Sponsor:IIMS-KL2 PI:Siddharth Prakash (UT-H) Co.I. (Sites):Bethea (UTSW), Fujise (UTMB) Study 3:Non-Alcoholic Steatohepititis (NASH) Trial Sponsor:UTMB funds PI:Abate (UTMB) Co.I. (Sites):Fallon (UT-H), others?

6 Key Initiative #2: Identify & support a multi-site NIH/ Federal trial within the TRCC Network Intent (why): Support a network trial Study 1:Neurological Emergencies Treatment Trials (NETT) Sponsor:NIH/NETT PI:Elizabeth Jones (UT-H) Co.I. (Sites):Mileski/Powell (UTMB) Study 2:Genetic Risks for Bicuspid Aortic Valve Disease Sponsor:IIMS-KL2 PI:Siddharth Prakash (UT-H) Co.I. (Sites):Bethea (UTSW), Fujise (UTMB) Study 3:Non-Alcoholic Steatohepititis (NASH) Trial Sponsor:UTMB funds PI:Abate (UTMB) Co.I. (Sites):Fallon (UT-H), others?

7 Key Initiative #3: Define standardized trial metrics Intent (why): Track performance in a standardized way across TRCC NIH Sponsored Trial Metrics # of grants 1st submitted % funded on 1st submission # of grants resubmitted (2nd submission) % funded on 2nd submission % requiring 2nd submission # Days from JIT to NOGA # Days from initial IRB submission for review to IRB Final Approval # Days from IRB Final Approval to first patient visit # Days from IRB Approval to any other final institutional approvals # Days from 1st patient visit to last patient visit % patient enrollment/accrual goal # Publications % First/Last Authored

8 INDUSTRY METRICS # CDA's submitted # CDA's approved # CTA / Contracts Submitted # CTA / Contracts Approved % Contracts finally Approved # Days for CDA approval from Sponsor to OSP # Days from initial OSP submission to Final CTA Approval # Days from initial IRB submission for review to IRB Final Approval # Days from IRB Final Approval to Final Sponsor Approval to enroll pts # Days from Sponsor Approval to 1st patient visit # Days from IRB Approval to any other final institutional approvals # Days from 1st patient visit to last patient visit % patient enrollment/accrual goal # Publications % First/Last Authored

9 INDUSTRY METRICS # CDA's submitted # CDA's approved # CTA / Contracts Submitted # CTA / Contracts Approved % Contracts finally Approved # Days for CDA approval from Sponsor to OSP # Days from initial OSP submission to Final CTA Approval # Days from initial IRB submission for review to IRB Final Approval # Days from IRB Final Approval to Final Sponsor Approval to enroll pts # Days from Sponsor Approval to 1st patient visit # Days from IRB Approval to any other final institutional approvals # Days from 1st patient visit to last patient visit % patient enrollment/accrual goal # Publications % First/Last Authored

10 Key Initiative #4: Produce list of industry master agreements for each institution Intent (why): Increase awareness of industry master agreements Need to inform Investigators in order to take advantage Committee #5 (Regulatory) working on issues of Master Trials Agreements (MTAs) Offices of Sponsored Programs (OSP) at each UT-site applies MTAs …but  Investigators unaware of MTA engage in negotiations;  Many CRO’s reject MTA’s and individually negotiate; …and OSP’s accept. There appear to be UT-System MTAs but also are local UT Institutional Agreements as well (i.e., the big “M” vs. the little “m”) ACTION ITEM(S): Generate The List! …for Investigators at each CTSA Site Gain help from UT System to “enforce” MTA’s and Sponsor/CRO compliance.

11 Key Initiative #4: Produce list of industry master agreements for each institution Intent (why): Increase awareness of industry master agreements Need to inform Investigators in order to take advantage Committee #5 (Regulatory) working on issues of Master Trials Agreements (MTAs) Offices of Sponsored Programs (OSP) at each UT-site applies MTAs …but  Investigators unaware of MTA engage in negotiations;  Many CRO’s reject MTA’s and individually negotiate; …and OSP’s accept. There appear to be UT-System MTAs but also are local UT Institutional Agreements as well (i.e., the big “M” vs. the little “m”) ACTION ITEM(S): Generate The List! …for Investigators at each CTSA Site Gain help from UT System to “enforce” MTA’s and Sponsor/CRO compliance. NOTE: Light at the End of the AE Tunnel !

12 Key Initiative #5: Implement I2B2 use at each institution to access patient pools (for preparatory to research and recruitment) Intent (why): Enable each institution to address prep research/ study feasibility Report Summary Environment Installed - All sites Budgeted- 3 of 4 sites In test- All sites Production- 3 of 4 sites Data Source Tables Epic- 3 of 4 sites Axium- 2 of 4 sites Other User Access - 3 of 4 sites IRB Approved- 1 of 4 sites  Budget Estimate  $300k-500k or less if UTH central site and level of site skill sets UT-Houston uses I2B2 for: Preparatory for Research Feasibility Patient Recruitment

13 Key Initiative #5: Implement I2B2 use at each institution to access patient pools (for preparatory to research and recruitment) Intent (why): Enable each institution to address prep research/ study feasibility Report Summary Environment Installed - All sites Budgeted- 3 of 4 sites In test- All sites Production- 3 of 4 sites Data Source Tables Epic- 3 of 4 sites Axium- 2 of 4 sites Other User Access - 3 of 4 sites IRB Approved- 1 of 4 sites  Budget Estimate  $300k-500k or less if UTH central site and level of site skill sets ACTION ITEM(S): Each site acknowledges need for a means to search EMR for “preparatory” feasibility and for “patient recruitment”. UT-Houston offers support for implementation of I2B2:  Sharing Best Practices; and/or  Providing Expertise and Support for using I2B2 at each site; or  Hosting an I2B2 application accessing site EMR’s Other sites may want to use other approaches to the same problem Will explore the use of Health Information Exchanges and/or local site Informatics approaches.

14 Key Initiative#5: Implement I2B2 use at each institution to access patient pools (for preparatory to research and recruitment) Intent (why): Enable each institution to address prep research/ study feasibility Report Summary Environment Installed - All sites Budgeted- 3 of 4 sites In test- All sites Production- 3 of 4 sites Data Source Tables Epic- 3 of 4 sites Axium- 2 of 4 sites Other User Access - 3 of 4 sites IRB Approved- 1 of 4 sites  Budget Estimate  $300k-500k or less if UTH central site and level of site skill sets ACTION ITEM(S): Each site acknowledges need for a means to search EMR for “preparatory” feasibility and for “patient recruitment”. UT-Houston offers support for implementation of I2B2:  Sharing Best Practices; and/or  Providing Expertise and Support for using I2B2 at each site; or  Hosting an I2B2 application accessing site EMR’s Other sites may want to use other approaches to the same problem Will explore the use of Health Information Exchanges and/or local site Informatics approaches.

Download ppt "TRCC Patient and Investigator Pools Workgroup November Status Report."

Similar presentations

Chiari Surgical Outcomes Trial PI: Bermans J. Iskandar and Timothy George with collaboration from John Kestle ASAP-funded pilot study ASAP-funded pilot.

Chiari Surgical Outcomes Trial PI: Bermans J. Iskandar and Timothy George with collaboration from John Kestle ASAP-funded pilot study ASAP-funded pilot.
Research Administration Capacity Building in an Established Institution Presenter: M.M.Aboud, MD Director of Research and Publications, MUHAS.

Research Administration Capacity Building in an Established Institution Presenter: M.M.Aboud, MD Director of Research and Publications, MUHAS.
USC Clinical Trials Office (CTO) Answers to CTOs who, what, when, and how questions Soheil Jadali Director, Clinical Trial Office.

USC Clinical Trials Office (CTO) Answers to CTOs who, what, when, and how questions Soheil Jadali Director, Clinical Trial Office.
Central IRBs An IRB Infoshort June 2014. Working Definition  A central IRB is one that serves as IRB of record for all of the sites engaged in a research.

Central IRBs An IRB Infoshort June Working Definition  A central IRB is one that serves as IRB of record for all of the sites engaged in a research.
UC BRAID: Co-creating and evaluating performance in a regional laboratory for conducting translational science UC BRAID Executive Committee: Steven Dubinett.

UC BRAID: Co-creating and evaluating performance in a regional laboratory for conducting translational science UC BRAID Executive Committee: Steven Dubinett.
Grants 101 Sponsored Projects Contracts and Subcontracts Daniel Deleon Senior Sponsored Projects Specialist Sponsored Projects Administration | Contracts.

Grants 101 Sponsored Projects Contracts and Subcontracts Daniel Deleon Senior Sponsored Projects Specialist Sponsored Projects Administration | Contracts.
Research Study Initiation Process 2014.06.14. GRU CLINICAL AND TRANSLATIONAL RESEARCH LABORATORY RESEARCH ANIMAL RESEARCH HUMAN RESEARCH GRU Clinical.

Research Study Initiation Process GRU CLINICAL AND TRANSLATIONAL RESEARCH LABORATORY RESEARCH ANIMAL RESEARCH HUMAN RESEARCH GRU Clinical.
ANPRM Single IRB Review mandated for multi-site domestic research P. Pearl O’Rourke, M.D. Partners Health Care.

ANPRM Single IRB Review mandated for multi-site domestic research P. Pearl O’Rourke, M.D. Partners Health Care.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.

CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
NIH Proposed Use of a Central IRB (C-IRB) for NIH-funded multi-site studies Committee on Clinical Research January 26, 2015 1.

NIH Proposed Use of a Central IRB (C-IRB) for NIH-funded multi-site studies Committee on Clinical Research January 26,
CUMC IRB Investigator Meeting IRB Frequently Asked Questions October 11, 2005.

CUMC IRB Investigator Meeting IRB Frequently Asked Questions October 11, 2005.
November 10, 20141 Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Patricia.

November 10, Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Patricia.
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) A single system for processing and reviewing applications.

National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) A single system for processing and reviewing applications.
Department of Medicine Research Retreat 2/9/13 Breakout Session #4: Enhancing Industry-sponsored Research Opportunities Marco Costa, MD, PHD Neal Meropol,

Department of Medicine Research Retreat 2/9/13 Breakout Session #4: Enhancing Industry-sponsored Research Opportunities Marco Costa, MD, PHD Neal Meropol,
Referral Management and Pull Through: The importance of having a plan to maximize outreach investments and support sites during the recruitment campaigns.

Referral Management and Pull Through: The importance of having a plan to maximize outreach investments and support sites during the recruitment campaigns.
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.

Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Copyright © 2013 Quintiles Quintiles Site Management Kim Davis, SSRM June 17, 2014.

Copyright © 2013 Quintiles Quintiles Site Management Kim Davis, SSRM June 17, 2014.
Research Policy and Procedure Task Force Report to RAF Jean S. Kutner, MD, MSPH Chief Medical Officer, University of Colorado Hospital February 12, 2015.

Research Policy and Procedure Task Force Report to RAF Jean S. Kutner, MD, MSPH Chief Medical Officer, University of Colorado Hospital February 12, 2015.
University Contracting The University of Arizona Office of Research and Contract Analysis (ORCA)

University Contracting The University of Arizona Office of Research and Contract Analysis (ORCA)
Taking the Plunge: Facilitating and Monitoring Collaborative Research and IRB Authorization Agreements Charles Hite Director, Biomedical & Research Ethics.

Taking the Plunge: Facilitating and Monitoring Collaborative Research and IRB Authorization Agreements Charles Hite Director, Biomedical & Research Ethics.

Similar presentations

Ads by Google